Adma Biologics reported $94.36M in Debt for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Adma Biologics ADMA:US $ 94.36M 0.49M
Agile Therapeutics AGRX:US $ 16.43M 0.4M
Alnylam Pharmaceuticals ALNY:US $ 433.8M 0.65M
Biocryst Pharmaceuticals BCRX:US $ 304.16M 10.51M
China Cord Blood CO:US 0 0
Dynavax Technologies DVAX:US $ 220.22M 0.26M
Kindred Biosciences KIN:US $ 19.87M 0.13M
Minerva Neurosciences NERV:US $ 0M 0M
Novavax NVAX:US $ 427.09M 3.23M
Omeros OMER:US $ 313.02M 433K
Takeda 4502:JP Y 4231359M 174502M